Measurement of Cholesterol Function Might Provide Link to Heart Attack Risk in Patients with Psoriasis
Scientists now report a new way to assess cholesterol that shows promise for evaluating the increased heart attack risk observed in patients with psoriasis, a common inflammatory skin disease. The new technique measures the function of high-density lipoprotein (HDL), known as “good” cholesterol, rather than HDL cholesterol concentration. The study, conducted by researchers from the National Heart Lung and Blood Institute at the National Institutes of Health (NIH), could broaden the use of the technique. The study appears in the online issue of the European Heart Journal.
This page was last updated on Friday, January 21, 2022